.AstraZeneca has actually discussed a very early consider the performance of its in-house antibody-d...
.After revealing a phase 3 launch based upon beneficial midstage results, iTeos and also GSK are act...
.The FDA ought to be a lot more open and also collaborative to unleash a surge in commendations of u...
.It is actually an extraordinarily occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and a...
.Atea Pharmaceuticals' antiviral has fallen short one more COVID-19 trial, however the biotech still...
.Neurocrine Biosciences' mental illness program pivot has actually fallen short. The biotech was una...
.Sanofi has actually brought in a late access to the radioligand event, spending 100 thousand euros ...
.After F2G's initial try to get a brand-new class of antifungal to market was actually hindered by t...
.Moderna has sworn to cut R&D costs by $1.1 billion by 2027. The selection to retract the spendin...
.Merely 4 months after Sanofi wager $80 million in ahead of time money on Key Rehabs' losmapimod, th...